Patents Assigned to University
-
Patent number: 8702957Abstract: A systems and apparatus for measuring non-electroactive materials in liquids using electrochemical detection. A first electrical activity of a electroactive material is detected in absence of a target non-electroactive material (Step 120). A second electrical activity of the electroactive material is detected in presence of the target non-electroactive material (Step 130). A difference between the first and second electrical activities is obtained, and based on the obtained difference, a concentration of the target non-electroactive material is identified (Step 140).Type: GrantFiled: June 29, 2007Date of Patent: April 22, 2014Assignees: Arizona Board of Regents for and on behalf of Arizona State University, EMD Millipore CorporationInventors: Joseph Wang, Aristotelis Dimitrakopoulos, Celine Le Ninivin, Stephane Mabic
-
Patent number: 8706434Abstract: The nonlinear systems measurement system includes two signal generators generating different sinusoidal frequencies. A spectrum analyzer measures all signals. A single software program synchronizes the instruments. The fetched measurements are kept in data registers in correct sequence for feeding into two curve fitting routines. The sinusoidal signals are fed to a suitable combiner for the expected frequencies and dynamic range of the UUT. The combined signal is applied to the UUT. Via a software-controlled single-pole, triple-throw RF switch, the amplitude of the UUT output and the two input signals are measured at every power step as amplitude I1 and amplitude I2. The amplitude of the output component from the UUT at f1-f2 is measured as IMD2 and the output component at 2f1-f2 is measured as IMD3. The measured I1 and IMD2 are fed to the curve-fitting routine 1, yielding r1. The measured I2 and IMD3 are fed to curve-fitting routine 2, yielding r2.Type: GrantFiled: September 12, 2013Date of Patent: April 22, 2014Assignee: King Fahd University of Petroleum and MineralsInventors: Muhammad Taher Abuelma'Atti, Ali Muhammad Taher Abuelma'Atti
-
Patent number: 8702390Abstract: A wind turbine includes a hub including at least three spaced projections and a hub cap; at least three blades each including a root plate at one end, with the root plate including a sleeve having a hole on a windward side; at least three shaft members each interconnecting the root plate and a corresponding projection; at least three sets of four abutment plates each secured to either side of the root plate or either side of the projection; U-shaped steel torsion bars each having both ends at an inclined angle of about 15 to 25 degrees fastened in the abutment plate and disposing the root plate at an angle of about 4 to 10 degrees with respect to the corresponding projection; a spring on the rotation shaft on a leeward side of the hub; and pins each installed in a hub cap and sticking into the hole.Type: GrantFiled: November 23, 2010Date of Patent: April 22, 2014Assignee: Chang Gung UniversityInventor: Ming-Tsung Sun
-
Patent number: 8705044Abstract: A method for detecting rotation includes providing a plurality of resonant waveguides generally adjacent to one another and optically coupled to one another. Each resonant waveguide of the plurality of resonant waveguides is configured to allow light to propagate along the resonant waveguide in a planar path. The method further includes propagating light along each path in a clockwise direction or along each path in a counterclockwise direction.Type: GrantFiled: September 20, 2011Date of Patent: April 22, 2014Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Matthew A. Terrel, Michel J. F. Digonnet, Shanhui Fan
-
Patent number: 8703023Abstract: A plasma treatment has been used to modify the surface of BNNTs. In one example, the surface of the BNNT has been modified using ammonia plasma to include amine functional groups. Amine functionalization allows BNNTs to be soluble in chloroform, which had not been possible previously. Further functionalization of amine-functionalized BNNTs with thiol-terminated organic molecules has also been demonstrated. Gold nanoparticles have been self-assembled at the surface of both amine- and thiol-functionalized boron nitride Nanotubes (BNNTs) in solution. This approach constitutes a basis for the preparation of highly functionalized BNNTs and for their utilization as nanoscale templates for assembly and integration with other nanoscale materials.Type: GrantFiled: June 19, 2012Date of Patent: April 22, 2014Assignee: The Regents of the University of CaliforniaInventors: Toby Sainsbury, Takashi Ikuno, Alexander K. Zettl
-
Patent number: 8701471Abstract: Method and system for background suppression in magneto-motive photoacoustic imaging of labeled target objects.Type: GrantFiled: October 13, 2011Date of Patent: April 22, 2014Assignee: University of Washington through its Center for CommercialiationInventors: Matthew O'Donnell, Xiaohu Gao
-
Patent number: 8705875Abstract: A facial image may be annotated with the plurality of facial landmarks. These facial landmarks may be points or regions of the face that are indicative, either alone or in combination with other facial landmarks, of at least one demographic characteristic. Demographic characteristics include, for example, age, race, and/or gender. Based on the demographic characteristic being analyzed, one or more of these facial landmarks may be selected and arranged into an input vector. Then, the input vector may be compared to one or more of the training vectors. An outcome of this comparison may involve in the given facial image being classified into a category germane to the analyzed demographic characteristic (e.g., an age range or age, a racial category, and/or a gender).Type: GrantFiled: September 7, 2011Date of Patent: April 22, 2014Assignee: University of North Carolina at WilmingtonInventor: Karl Ricanek, Jr.
-
Patent number: 8703009Abstract: The present invention provides for a lithium ion battery and process for creating such, comprising higher binder to carbon conductor ratios than presently used in the industry. The battery is characterized by much lower interfacial resistances at the anode and cathode as a result of initially mixing a carbon conductor with a binder, then with the active material. Further improvements in cycleability can also be realized by first mixing the carbon conductor with the active material first and then adding the binder.Type: GrantFiled: November 6, 2009Date of Patent: April 22, 2014Assignee: The Regents of the University of CaliforniaInventors: Gao Liu, Vincent S. Battaglia, Honghe Zheng
-
Patent number: 8703200Abstract: The present invention provides methods for reducing, reversing or inhibiting neovascularization in a tissue of a mammalian subject having a pathological condition involving neovascularization by administration in vivo of nanoceria particles (cerium oxide nanoparticles) to the subject. The method of the invention is useful, for example, for reducing, treating, reversing or inhibiting neovascularization in ocular tissue such as the retina, macula or cornea; in skin; in synovial tissue; in intestinal tissue; or in bone. In addition, the method of the invention is useful for reducing or inhibiting neovascularization in a neoplasm (tumors), which can be benign or malignant and, where malignant, can be a metastatic neoplasm. As such, the invention provides compositions, which contain nanoceria particles and are useful for reducing, treating, reversing or inhibiting angiogenesis in a mammalian subject.Type: GrantFiled: April 24, 2009Date of Patent: April 22, 2014Assignee: The Board of Regents of the University of OklahomaInventors: James F. McGinnis, Xiaohong Zhou, Lily L. Wong, Sudipta Seal
-
Patent number: 8702792Abstract: A device delivers a chemical or biological agent, the device comprises an imprint molecule (IM) to be delivered by the device; an electroactive molecularly imprinted polymer (EMIP) imprinted with the imprint molecule, the EMIP having a plurality of binding sites capable of binding the imprint; and an electric potential producing member (EPM), the EPM being capable of producing an electric potential between the EPM and the EMIP; whereby when the EMIP has a predetermined density of imprint molecule bound at the binding sites, and whereby when a sufficient potential is produced between the EPM and the EMIP, the imprint molecule is released from the binding site and thereby delivered by the device.Type: GrantFiled: March 22, 2012Date of Patent: April 22, 2014Assignee: Saint Louis UniversityInventors: Shelley D. Minteer, Jenny Ulyanova
-
Patent number: 8703744Abstract: Provided are methods of reducing cellular cholesterol levels using lipid particles that are capable of cellular entry. Such lipid particles may be used for treating or preventing a disease or condition that is caused by or associated with an increased cellular cholesterol level and for treating or preventing a disease or condition, that is caused by or associated with a virus, that relies on cellular cholesterol for its replication.Type: GrantFiled: March 26, 2010Date of Patent: April 22, 2014Assignee: The Chancellor, Masters and Scholars of the University of OxfordInventors: Stephanie Pollock, Raymond Dwek, Nicole Zitzmann
-
Patent number: 8703801Abstract: New chiral and achiral oxy-substituted cyclopentyl pyridinone diketocarboxamides and their derivatives and methods for their preparations are disclosed. The compounds include tautomers, regioisomers and geometric isomers. These complex carboxamides are designed as inhibitors of HIV replication through inhibition of HIV integrase. The compounds are useful in the prevention or treatment of infection by HIV and in the treatment of AIDS and ARC, either as the compounds, or as pharmaceutically acceptable salts, with pharmaceutically acceptable carriers, used alone or in combination with antivirals, immunomodulators, antibiotics, vaccines, and other therapeutic agents, especially other anti-HIV compounds (including other anti-HIV integrase agents), which can be used to create combination anti-HIV cocktails. Methods of treating AIDS and ARC and methods of treating or preventing infection by HIV are also described.Type: GrantFiled: December 7, 2010Date of Patent: April 22, 2014Assignee: University of Georgia Research Foundation, Inc.Inventors: Vasu Nair, Maurice O. Okello, Abdumalik A. Nishonov, Sanjaykumar Mishra
-
Patent number: 8704575Abstract: Active directional couplers are provided. In accordance with certain embodiments of the invention, the subject active directional couplers are tunable. The tuning is accomplished via varactors connected to the lines of the active directional couplers. Active directional elements are provided between different lines of the subject active directional couplers to control a signal path between ports of the different lines. The active directional elements are selected from diodes, transistors, inverting amplifiers, non-inverting amplifiers, differential amplifiers, and active baluns. The lines include a phase shift element between the two ports of each line. The phase shift element is selected from a transmission line, a delay line, and a phase shifter. Advantageously, the subject lines do not have to be designed for ideal phase shifting and can be designed at near 90° or near ?/4 values.Type: GrantFiled: June 18, 2012Date of Patent: April 22, 2014Assignee: University of Florida Research Foundation, IncorporatedInventors: Byul Hur, William Richard Eisenstadt
-
Patent number: 8703829Abstract: The invention provides compounds of Formula (I): R1?R2??(I) wherein R1 and R2 have any of the values or specific values defined herein, as well as compositions comprising such compounds and therapeutic methods comprising the administration of such compounds.Type: GrantFiled: May 23, 2012Date of Patent: April 22, 2014Assignee: University of Louisville Research Foundation, Inc.Inventors: Gerald B. Hammond, Bo Xu, Paula J. Bates
-
Patent number: 8706188Abstract: A method for musculoskeletal tissue segmentation used in magnetic resonance imaging (MRI) is provided. MRI image data is collected using at least two different contrast mechanisms. Voxel values from data from each contrast mechanism are used as elements of a feature vector. The feature vector is compared with classification boundaries to classify musculoskeletal tissue type of the voxel. The previous two steps are repeated for a plurality of voxels. An image is generated from the classified musculoskeletal tissue types for the plurality of voxels to provide a musculoskeletal segmentation image.Type: GrantFiled: June 4, 2008Date of Patent: April 22, 2014Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Seungbum Koo, Brian A. Hargreaves, Garry E. Gold
-
Patent number: 8703487Abstract: The invention provides compositions for making erythroid progenitor cells that comprise in vitro-activated bone marrow mesenchymal stem cells and embryoid bodies (EBs) or pluripotent stem cells, and methods for making and using them, including ameliorating (e.g., preventing or treating) anemia and/or stimulating erythropoiesis. In one embodiment, the invention provides methods of increasing propensity of committed stem cell differentiation towards the erythroid lineage.Type: GrantFiled: November 30, 2010Date of Patent: April 22, 2014Assignee: The Regents of the University of CaliforniaInventor: Ewa Carrier
-
Patent number: 8704133Abstract: A silver-containing antiseptic welding flux for stainless steel includes 0.1-0.5 wt % of silver, 30-54 wt % of silicon dioxide, 20-40 wt % of titanium dioxide, 10-20 wt % of chromium oxide, 5-20 wt % of molybdenum oxide, 5-10 wt % of molybdenum sulfide, and 5-10 wt % of halide.Type: GrantFiled: March 18, 2011Date of Patent: April 22, 2014Assignee: National Pingtung University of Science and TechnologyInventor: Kuang-Hung Tseng
-
Patent number: 8706216Abstract: Methods and apparatus for a three-stage atrial cardioversion therapy that treats atrial arrhythmias within pain tolerance thresholds of a patient. An implantable therapy generator adapted to generate and selectively deliver a three-stage atrial cardioversion therapy and at least two leads, each having at least one electrode adapted to be positioned proximate the atrium of the patient. The device is programmed for delivering a three-stage atrial cardioversion therapy via both a far-field configuration and a near-field configuration of the electrodes upon detection of an atrial arrhythmia. The three-stage atrial cardioversion therapy includes a first stage for unpinning of one or more singularities associated with an atrial arrhythmia, a second stage for anti-repinning of the one or more singularities, both of which are delivered via the far-field configuration of the electrodes, and a third stage for extinguishing of the one or more singularities delivered via the near-field configuration of the electrodes.Type: GrantFiled: January 12, 2012Date of Patent: April 22, 2014Assignee: The Washington UniversityInventors: Igor Efimov, Wenwen Li, Ajit Janardhan
-
Patent number: 8704204Abstract: Disclosed herein are nanoscale devices comprising one or more ferroelectric nanoshells characterized as having an extreme curvature in at least one spatial dimension. Also disclosed are ferroelectric field effect transistors and metal ferroelectric metal capacitors comprising one or more ferroelectric nanoshells. Methods for controlling spontaneous ferroelectric polarization in nanoshell devices are also disclosed.Type: GrantFiled: December 2, 2009Date of Patent: April 22, 2014Assignee: Drexel UniversityInventors: Jonathan E. Spanier, Stephen S. Nonnenmann, Oren David Leaffer
-
Patent number: 8703798Abstract: An indoloquinoline wherein the quarternary N-5 atom is a straight C(1-5) chain, a branched C(1-5) chain, a heteroatom chain, a straight chain substituted terminally by a cycloalkyl or aromatic ring, a branched chain substituted terminally by a cycloalkyl or aromatic ring, a heteroatom chain substituted terminally by a cycloalkyl or aromatic ring; the 10 position is N—R10, O, S, S?O, CH2, or C?O, where R10 is a branched C(1-5) chain, a heteroatom chain, a straight chain substituted terminally by a cycloalkyl or aromatic ring, a branched chain substituted terminally by a cycloalkyl or aromatic ring, a heteroatom chain substituted terminally by a cycloalkyl or aromatic ring. In one embodiment the quarternary N-5 atom is —CH3 and the 10 position is N—(CH2)5-Ph.Type: GrantFiled: February 24, 2012Date of Patent: April 22, 2014Assignee: Florida A&M UniversityInventor: Seth Y. Ablordeppey